CNR2 and Alzheimer disease: Therefore, the precise role of CB2 in neurodegenerative disease remains unclear, although these data collectively indicate that targeting the CB2 receptor could prevent or reverse the formation of neuritic plaques and, importantly, reverse memory impairments in AD.